Grants per year
- 1 - 25 out of 78 results
Search results
-
Active
-
Acceleration Centers of Enrollment (ACE)
Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital
8/1/24 → 7/31/26
Project: Research project
-
Prot #EDG-5506-201: A Phase 2 Randomized, Double-blind, Placebo controlled Study to Evaluate the Effect of EDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults and Adolescents with Becker Muscular Dystrophy
Ajroud-Driss, S. (PD/PI)
12/14/23 → 12/14/26
Project: Research project
-
ALS/MND Natural History Repository
Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital
12/1/23 → 11/30/24
Project: Research project
-
An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine
Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke
9/25/23 → 8/31/27
Project: Research project
-
Clinic-based Multicenter ALS Natural History Data Collection- Supplement
Ajroud-Driss, S. (PD/PI)
University of Minnesota, Food and Drug Administration
9/1/23 → 8/31/26
Project: Research project
-
(OE) Prot #CNMAu8.EAP02: A Second Expanded Access Protocol for Amyotrophic Lateral Sclerosis with CNM-Au8
Ajroud-Driss, S. (PD/PI)
5/11/23 → 5/11/26
Project: Research project
-
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) G to Master Protocol DNL343
Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital, Denali Therapeutics Inc.
3/23/23 → 12/4/24
Project: Research project
-
UMMS-ASO-STMN2 Study - Year 2
Ajroud-Driss, S. (PD/PI), Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)
11/1/22 → 12/31/24
Project: Research project
-
Clinic-based Multicenter ALS Natural History Data Collection
Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)
University of Minnesota, Food and Drug Administration
9/20/22 → 8/31/26
Project: Research project
-
A Phase 3b, Multicenter, Randomized, Double-blind Extension Study to Evaluate the Continued Efficacy and Safety of Oral Edaravone Administered for an Additional Period of up to 48 Weeks Following Study MT-1186-A02 in Subjects with Amyotrophic Lateral Scle
Ajroud-Driss, S. (PD/PI)
ICON Clinical Research, LLC, Mitsubishi Tanabe Pharma America, Inc.
8/8/22 → 8/8/25
Project: Research project
-
Prot#A35-006: EXPANDED ACCESS TRIAL OF AMX0035 FOR AMYOTROPHIC LATERAL SCLEROSIS: An Intermediate Size, Expanded Access Protocol to Provide AMX0035, A Fixed Combination of Sodium Phenylbutyrate(PB) and Taurursodiol (TURSO), for the Treatment of Adult Pati
Ajroud-Driss, S. (PD/PI)
6/8/22 → 6/8/25
Project: Research project
-
Prot#WP-0512-003: A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)
DP Clinical, Inc., Woolsey Pharmaceuticals, Inc.
3/3/22 → 3/22/25
Project: Research project
-
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) E to Master Protocol TREHALOSE S-005
Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital, NexMed, Inc.
3/1/22 → 12/4/24
Project: Research project
-
Protocol Number: A35-004 - Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients with Amyotrophic Lateral Sclerosis (ALS)
Ajroud-Driss, S. (PD/PI)
Julius Clinical Research B.V, Amylyx Pharmaceuticals, Inc.
1/12/22 → 1/12/25
Project: Research project
-
Prot #233AS303: A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation
Ajroud-Driss, S. (PD/PI)
8/12/21 → 5/31/26
Project: Research project
-
Prot #BASICHR0053: Evaluation of digital technologies for home-based assessment of ALS patients
Ajroud-Driss, S. (PD/PI)
Novartis Pharmaceuticals Corporation
8/3/21 → 12/6/24
Project: Research project
-
Prot#AB19001: A Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Parallel Groups, Phase 3 Study to Compare the Efficacy and Safety of Masitinib in Combination with Riluzole Versus Placebo in Combination with Riluzole in the Treatmen
Ajroud-Driss, S. (PD/PI)
2/26/21 → 12/31/24
Project: Research project
-
Prot# 233AS102: An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB067 Administered to Previously Treated Adults with Amyotrophic Lateral Sclerosis Caused by Superoxide Dismutase 1 M
Ajroud-Driss, S. (PD/PI)
Quintiles, Inc., Biogen MA Inc.
11/24/20 → 9/30/25
Project: Research project
-
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) D to Master Protocol PRIDOPIDINE | Home Spirometry and Open-Label Extension (OLE) Period
Ajroud-Driss, S. (PD/PI), Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital, Prilenia Neurotherapeutics Ltd
9/4/20 → 3/14/25
Project: Research project
-
Oxidative Markers and Efficacy in ALS/MND Phenotypes Treated with Edaravone: Proof of Concept
Ajroud-Driss, S. (PD/PI)
Loma Linda University, Mitsubishi Tanabe Pharma America, Inc.
9/2/20 → 9/2/25
Project: Research project
-
HEALEY ALS Platform Trial Platform-Level Site Activities
Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital
3/23/20 → 12/31/24
Project: Research project
-
Master Clinical Trial Agreement - HEALEY ALS Platform Trial
Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)
Massachusetts General Hospital
12/5/19 → 12/4/24
Project: Research project